Hypertension

Health Condition

High Blood Pressure (Hypertension)

  • Blood Pressure Monitors

    Blood pressure is an important marker of health and a home blood pressure monitor is a wonderful tool for ensuring your numbers stay in the healthy range. A home monitor may lead to savings in health care costs, because you may need fewer visits to the doctor’s office, and it has the advantage of eliminating “white coat hypertension,” the falsely high blood pressure readings that can occur due to the stress of being in the doctor’s office.

    All blood pressure monitors have three key parts: the cuff, the gauge, and the stethoscope. On many models, the stethoscope is a built in sensor. Use this buying guide to find the right monitor to fit your health needs, lifestyle, and budget. As you choose a blood pressure monitor, keep the following in mind:

    • If you have an abnormal heartbeat, home readings can be inaccurate. Talk to your doctor about whether this is a concern for you.
    • Your health insurance may partially or fully cover the cost of a home blood pressure monitor. Call to find out before you purchase one.
    • If your arm is smaller or larger than average, you may need a smaller or larger cuff. If you are unsure whether an arm cuff will fit, ask the pharmacist if you can try before buying.
    • Manual Monitors

      What they are: With manual monitors, the user inflates the cuff around the arm and listens for the pulse through a stethoscope to determine blood pressure as the cuff deflates.

      Why to buy: Once you master their use, manual monitors are accurate and less expensive than most automated models.

      Things to consider: Manual monitors are more difficult to use than automated models, requiring more practice to learn or even another person to operate it.

    • Semi-Automatic & Automatic Arm Sleeve Monitors

      What they are: These devices have built-in stethoscopes with readings displayed on a digital screen. With semi-automatic monitors, the user inflates the cuff, while fully automatic monitors inflate the cuff for you. 

      Why to buy: These monitors typically are more expensive than manual options, but may vary in price depending on features. If you are looking for the most accurate and easiest way to store and track blood pressure readings over time, these models are a good option. 

      Things to consider: If you’re more concerned about cost than ease of use, manual options may be a better choice.

    • Wrist & Finger Monitors

      What they are: These newer devices allow a smaller cuff to be placed on the wrist or on a finger, instead of on the upper arm. 

      Why to buy: Putting on and taking off these monitors is easier than manipulating an arm cuff.  

      Things to consider: Although they tend to fall in the same cost range as automatic arm monitors, these monitors tend to be less accurate and lead to more errors than arm cuff monitors.

    • Advanced Features

      What they are: Depending on your budget and health tracking needs, you may want to consider spending extra dollars to purchase a digital monitor with more advanced features, including memory to store readings over time and computer software to track and graph your readings on a computer or mobile device. 

      Why to buy: Advanced features allow you to track blood pressure over time. Along with a few observations and notes, this can help you uncover connections between your behaviors, such as what you’ve eaten or how much you’ve exercised, and your blood pressure readings. Understanding these connections can help you take positive, effective actions to improve your health. 

      Things to consider: Advanced features cost more and may take more time to learn how to use. Many come with good instructions but if you’re uncomfortable with computers you may find these features take significant effort to learn and use.

  • Scales

    Many people track body weight to ensure they stay in a healthy range, and for the millions of people who go on a weight-loss diet each year, a good-quality scale is an essential tool. As you choose a scale, keep the following in mind.

    • Health insurance may cover the cost of a home scale, or you may be able to use a health savings account to pay for one. Call your insurance provider to find out before making your purchase.
    • Place the scale on a flat, hard surface for the most accurate readings.
    • Heavier weight that makes it difficult for scales to shift around can be an indication of higher quality.
    • Before purchasing, weigh yourself five times in a row. If you get the same number all five times, the scale has good precision.
    • To check accuracy, compare weight from your home scale against weight on an upright scale at a doctor’s office. These numbers should be the same or very close to one another.
    • Many things cause short-term weight fluctuations, including how much and what you’ve eaten, whether you’ve exercised recently, whether you’re properly hydrated, what you’re wearing, and time of day. Weigh yourself once per week or less if you’re trying to lose weight; daily fluctuations can lead to dieting frustration.
    • Basic Mechanical Scale (Dial)

      What they are: Mechanical, or analog, scales have a dial readout displaying weight in pounds and kilograms.

      Why to buy: Mechanical scales tend to be less expensive, don’t require a battery, may come with extra large numbers for ease of use, and are the simplest to use.

      Things to consider: Over time, mechanical scales may consistently add or subtract a few pounds. Most come with a tension knob to adjust the scale as required

    • Digital Scale with Added Features

      What they are: These scales give a digital (and sometimes audio) readout of weight.

      Why to buy: Digital scales may have features to allow storing and tracking weight over time, may have the ability to switch between pounds and kilograms, and may provide voice readouts of weight. If several family members are using one scale, consider a model with a multiple-user memory function.

      Things to consider: If you’re concerned about cost and ease of use, a mechanical scale may be a better choice. Digital scales require batteries, which need to be replaced when they wear out, so consider buying a rechargeable set for best value.

    • Digital Scale with Full Features

      What they are: Digital scales with full features can measure and track body weight, body mass index, percent body fat and lean body mass, hydration status, and bone mass.

      Why to buy: These models are a good choice for those who want the most information about weight and related measures. Tracking fat and lean body mass can motivate some people to more consistently follow a healthy diet and exercise plan.

      Things to consider: Extra features often mean higher cost. These models provide an idea of fat and lean mass, bone mass, and hydration, but are not always completely accurate. You should not rely on results from these scales to make important medical decisions. Digital scales require batteries, which need to be replaced when they wear out, so consider buying a rechargeable set for best value.

  • Pedometers

    Walking is a fun and relatively easy way to get heart-healthy cardio while burning fat and calories. To maintain a healthy weight and stay active, try walking about 10,000 steps each day (approximately five miles). Do you want to lose a few extra pounds? Just step up the amount of walking each day. Whatever your goals, a pedometer is an easy way to keep track of your steps on the road to success.

    Remember to check with your doctor before starting any exercise program, especially if you are overweight or managing a health condition.

    • Basic Pedometers

      What they are:A pedometer is a small device, usually worn on your belt or clipped to a pocket, which counts how many steps you take in a day. There are two types:

      • Pendulum: Placement of a pendulum pedometer is vital for accuracy and they must remain in a vertical position on the hip or waist band.
      • Piezoelectric accelerometers: These can be placed anywhere on the front of the body, and some can even be kept in a pocket or on a neck lanyard and still provide accurate step counts.

      Most pedometers weigh only a few ounces and include a security strap to attach to clothing to prevent you from losing it.

      Why to buy: Pedometers are an easy way to track your daily exercise and overall health. Beyond counting steps, many pedometers track the distance in miles, amount of time you’ve been active, and total calories burned.

      Things to consider: When choosing a pedometer, consider the size of the display screen and the ease of reading results. Pendulum-style pedometers are generally less expensive than accelerometers, but the counting of incidental steps can be frustrating. Advantages of accelerometer pedometers are there are no moving parts and they remain silent as they record every step you take. Remember you’ll need to set your average step length or stride length in order for the pedometer to be accurate. Read the instructions on your pedometer carefully; most ask for the step length and explain how to measure it properly. Also note that some pedometers reset at midnight so you’re ready to go each morning, while others require you to manually reset them. Look at whether you need to change the batteries regularly or if it’s rechargeable through a USB connection to your computer.

    • Specialized Pedometers

      What they are: Monitors that help you measure steps plus other tracking, such as heart rate, calories burned, and so on.

      Why to buy: Pedometers with features that track heart rate and so on are handy for keeping an eye on your cardiovascular health, too. More advanced models include a memory function to save your accomplishments and some can upload data to a website, so you can easily track your results online and share with your doctors and friends.

      Things to consider: When investing in tools to support your health goals, sometimes simplest is best, but other times it can be helpful to combine goals and look for a device that will give you other helpful information, such as heart rate or trackable online information.

  • Smoking Cessation Products

    Many things motivate people to quit tobacco: being a good role model, wanting to reduce others’ exposure to second hand smoke, saving money, and wanting to feel better and improve health. Whatever your reason, keep in mind that quitting cold turkey is the least successful method for kicking cigarettes for good. Fortunately, many over-the-counter and prescription quit aids have been developed that may significantly improve your odds of success. As you figure out which quit-smoking aids best meet your needs, keep the following in mind:

    • Some treatments to stop smoking are covered by health insurance. Check with your carrier to see.
    • Some products are available both over the counter (behind the pharmacy counter) and with a prescription. Ask your health insurance about whether you need a prescription for coverage or reimbursement.
    • Try, try, and try again. People who successfully quit smoking rarely do so on the first attempt. If you’ve tried before without success, don’t be discouraged. Consider a different quit aid—the nicotine patch instead of gum, or adding in a prescription medication—and evaluate what worked and didn’t work to keep you on track during past attempts to quit.
    • Start with your doctor, nurse, or pharmacist. They can offer invaluable advice and connect you with programs for people trying to quit, including support groups and other resources. Consider taking advantage of these supports, because most people do best when they combine quit-smoking products with behavior change programs.
    • When selecting a product, consider your current medications and health conditions. Consult your doctor or pharmacist if unsure about whether any particular smoking cessation product is safe for you.
    • Use nicotine replacement carefully and follow all package directions. Some people load up on patches, gum, and sprays yet continue to smoke at the same time. This can overload your system with nicotine, resulting in jitters, rapid heart rate, high blood pressure, and trouble sleeping. Some products can be used together, so ask your doctor or pharmacist what’s best for you.
    • Nicotine Patches

      What they are: Nicotine patches are similar to an adhesive bandage; you place one on your skin and it releases a constant amount of nicotine into the body while you wear it. They come in different sizes, with larger sizes delivering more nicotine.

      Why to buy: Nicotine replacement patches are available over the counter or with a prescription, and typically cost less per day than a pack of cigarettes. Patches are convenient and easy to use and can be removed during sleep to lessen the likelihood of insomnia. Due to the constant, slow release of nicotine, you are not likely to develop a craving for a patch; it doesn’t provide the intense delivery of a cigarette.

      Things to consider: Unlike smoking, which delivers a large dose of nicotine to your body within seconds, nicotine from a patch can take up to three hours to get into the body. For this reason, putting on a patch when a cigarette craving strikes is not effective. The nicotine patch reduces smoking withdrawal symptoms, such as lack of concentration and irritability.

    • Nicotine Gum

      What they are: Nicotine replacement gums are available over the counter or with a prescription and typically cost much less per day than a pack of cigarettes. Gum comes in different strengths to provide the amount of nicotine you need, based on your previous smoking habits.

      Why to buy: Gums are relatively convenient and easy to use, although you must remember to keep yours with you, because it must be chewed frequently to deliver enough nicotine to manage cravings. Though it cannot get nicotine into your body quite as quickly as a cigarette, gum delivers nicotine within minutes, which is far faster than a patch.

      Things to consider: Nicotine gum should not be used with cigarettes and you should not eat or drink for 15 minutes before or while using the gum. To chew enough gum to quell cravings, most people need between 15 and 30 pieces per day, chewed off and on for about 30 minutes. Nicotine gum should not be chewed continuously like regular gum and should never be swallowed. It is chewed a few times to break it down and then placed in between your gum and cheek for 10 or 15 minutes, chewed again for a bit, then put back into the cheek. Continuous chewing may cause stomachaches.

    • Lozenges & Lollipops

      What they are: Nicotine replacement lozenges and lollipops are available over the counter or with a prescription. They may cost a bit more than patches or gum, but typically less than a pack of cigarettes. Lozenges and lollipops come in different strengths to provide the amount of nicotine you need, based on your previous smoking habits.

      Why to buy: Some people don’t like to chew gum and prefer sucking on a candy to replace nicotine when quitting smoking. These products are relatively convenient, but you must remember to keep them on hand to use throughout the day. Lozenges and lollipops deliver nicotine within a few minutes, similar to gum.

      Things to consider: Nicotine lozenges and lollipops should not be used with cigarettes and you should not eat or drink for 15 minutes before or while they are in your mouth. Nicotine lozenges and lollipops should not be chewed or swallowed as this can lead to heartburn and stomachaches. Some people find these products irritate the mouth and throat.

    • Nicotine Nasal Sprays & Inhalers

      What they are: These products deliver nicotine through a spray into the nose or are inhaled through the mouth. They are available by prescription only.

      Why to buy: Nicotine nasal sprays and inhalers deliver nicotine as quickly as a cigarette, making them particularly helpful for people who are highly dependent on tobacco. For the person who smokes more than a pack of cigarettes per day, these products may be very effective.

      Things to consider: You need a prescription to obtain a nicotine spray or inhaler. Sprays cost about the same as gums and patches, but inhalers can be more expensive. They may be covered by insurance, which can help reduce the cost.

    • Non-Nicotine Prescription Medications

      What they are: Two different non-nicotine prescription medications may help people quit smoking by reducing the desire to smoke.. These are bupropion (brand name Zyban) and varenicline (brand name Chantix).

      Why to buy: These medications may significantly increase the quit smoking success rate beyond using nicotine replacement alone. They can be used in conjunction with nicotine replacement, further increasing success rates of quitting.

      Things to consider: Like all prescription medications, these drugs can have side effects. Many people tolerate them well, but some people experience very serious side effects, particularly from varenicline, which in some people causes hostility, agitation, anger, aggression, depressed mood, anxiety, paranoia, confusion, mania, or suicidal thoughts or actions. These can develop when a person begins taking the medication, after several weeks of treatment, or after stopping the varenicline. Insurance may not cover the cost of these medications.

References

1. Naveed M,Hejazi V, Abbas M, et al. Chlorogenic acid (CGA): A pharmacological review and call for further research. Biomed Pharmacother 2018;97:67–74.

2. Pimpley V, Patil S,Srinivasan K, et al. The chemistry of chlorogenic acid from green coffee and its role in attenuation of obesity and diabetes. Prep Biochem Biotechnol 2020;50:969–78.

3. Han B, Nazary-Vannani A, Talaei S, et al. The effect of green coffee extract supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Phytother Res 2019 Nov;33:2918–26.

4. Bercea CI, Cottrell GS, Tamagnini F, et al. Omega-3 polyunsaturated fatty acids and hypertension: a review of vasodilatory mechanisms of docosahexaenoic acid and eicosapentaenoic acid. Br J Pharmacol 2021;178:860–77.

5. Matsumoto C, Yoruk A, Wang L, et al. Fish and omega-3 fatty acid consumption and risk of hypertension. J Hypertens 2019 06;37(6):1223–9.

6. Yang B, Shi MQ, Li ZH, et al. Fish, Long-Chain n-3 PUFA and Incidence of Elevated Blood Pressure: A Meta-Analysis of Prospective Cohort Studies. Nutrients 2016 Jan;8(1):58.

7. Miller PE, Van Elswyk M, Alexander DD. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens 2014 Jul;27(7):885–96.

8. Ried K. Garlic lowers blood pressure in hypertensive subjects, improves arterial stiffness and gut microbiota: A review and meta-analysis. Exp Ther Med 2020;19:1472–8.

9. Schwingshackl L, Missbach B, Hoffmann G. An umbrella review of garlic intake and risk of cardiovascular disease. Phytomedicine. 2016 Oct;23(11):1127–33.

10. Xiong XJ, Wang PQ, Li SJ, et al. Garlic for hypertension: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine. 2015;22:352–61.

11. Ried K, Travica N, Sali A. The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at Heart trial. Integr Blood Press Control 2016;9:9–21.

12. Mahdavi-Roshan M, Nasrollahzadeh J, Mohammad Zadeh A, Zahedmehr A. Does Garlic Supplementation Control Blood Pressure in Patients with Severe Coronary Artery Disease? A Clinical Trial Study. Iran Red Crescent Med J 2016;18:e23871.

13. Zhu Y, Anand R, Geng X, et al. A mini review: garlic extract and vascular diseases. Neurol Res 2018;40:421–425.

14. Choudhary PR, Jani RD, Sharma MS. Effect of Raw Crushed Garlic (Allium sativum L.) on Components of Metabolic Syndrome. J Diet Suppl 2018;15:499–506.

15. Bahadoran Z, Mirmiran P, Momenan AA, et al. Allium vegetable intakes and the incidence of cardiovascular disease, hypertension, chronic kidney disease, and type 2 diabetes in adults: a longitudinal follow-up study. J Hypertens 2017;35:1909–16.

16. Odai T, Terauchi M, Kato K, et al. Effects of Grape Seed Proanthocyanidin Extract on Vascular Endothelial Function in Participants with Prehypertension: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients 2019;11:2844.

17. Park E, Edirisinghe I, Choy YY, et al. Effects of grape seed extract beverage on blood pressure and metabolic indices in individuals with pre-hypertension: a randomised, double-blinded, two-arm, parallel, placebo-controlled trial. Br J Nutr 2016;115:226–38.

18. Belcaro G, Ledda A, Hu S, et al. Grape seed procyanidins in pre- and mild hypertension: a registry study. Evid Based Complement Alternat Med 2013;2013:313142.

19. Zhang H, Liu S, Li L, et al. The impact of grape seed extract treatment on blood pressure changes: A meta-analysis of 16 randomized controlled trials. Medicine (Baltimore) 2016;95:e4247.

20. Jeffery TD, Richardson ML. A review of the effectiveness of hibiscus for treatment of metabolic syndrome. J Ethnopharmacol 2021;270:113762.

21. Amos A, Khiatah B. Mechanisms of Action of Nutritionally Rich Hibiscus sabdariffa's Therapeutic Uses in Major Common Chronic Diseases: A Literature Review. Journal of the J Am Coll Nutr 2021:1–8.

22. Jalalyazdi M, Ramezani J, Izadi-Moud A, et al. Effect of hibiscus sabdariffa on blood pressure in patients with stage 1 hypertension. J Adv Pharm Technol Res 2019;10:107–11.

23. Al-Anbaki M, Nogueira RC, Cavin AL, et al. Treating Uncontrolled Hypertension with Hibiscus sabdariffa When Standard Treatment Is Insufficient: Pilot Intervention. J Altern Complement Med 2019;25:1200–05.

24. Serban C, Sahebkar A, Ursoniu S, et al. Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials. J Hypertens 2015;33:1119–27.

25. Seck SM, Doupa D, Dia DG, et al. Clinical efficacy of African traditional medicines in hypertension: A randomized controlled trial with Combretum micranthum and Hibiscus sabdariffa. J Hum Hypertens 2017;12;32:75–81.

26. Elkafrawy N, Younes K, Naguib A, et al. Antihypertensive efficacy and safety of a standardized herbal medicinal product of Hibiscus sabdariffa and Olea europaea extracts (NW Roselle): A phase-II, randomized, double-blind, captopril-controlled clinical trial. Phytother Res 2020;34:3379–87.

27. Bourqui A, Niang EAB, Graz B, et al. Hypertension treatment with Combretum micranthum or Hibiscus sabdariffa, as decoction or tablet: a randomized clinical trial. J Hum Hypertens 2020 Sep.

28. Nwachukwu DC, Aneke EI, Obika LF, et al. Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinopril. Indian J Pharmacol 2015;47:540–5.

29. Nwachukwu DC, Aneke E, Nwachukwu NZ, et al. Effect of Hibiscus sabdariffaon blood pressure and electrolyte profile of mild to moderate hypertensive Nigerians: A comparative study with hydrochlorothiazide. Niger J Clin Pract 2015;18:762–70.

30. Kostov K, Halacheva L. Role of Magnesium Deficiency in Promoting Atherosclerosis, Endothelial Dysfunction, and Arterial Stiffening as Risk Factors for Hypertension. Int J Mol Sci 2018;19:1724.

31. Wu J, Xun P, Tang Q, et al. Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Nutr J 2017;16:60.

32. Han H, Fang X, Wei X, et al. Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. Nutr J 2017;16:26.

33. Zhang X, Li Y, Del Gobbo LC, et al. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension 2016;68:324–33.

34. Dibaba D, Xun P, Song Y, et al. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2017;106:921–9.

35. Rosanoff A, Plesset MR. Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis.Magnes Res. 2013;26:93–9.

36. Jiki Z, Lecour S,Nduhirabandi F. Cardiovascular Benefits of Dietary Melatonin: A Myth or a Reality? Front Physiol 2018;9:528.

37. Pechanova O, Paulis L, Simko F. Peripheral and central effects of melatonin on blood pressure regulation.Int J Mol Sci 2014;15:17920–37.

38. Baker J, Kimpinski K. Role of melatonin in blood pressure regulation: An adjunct anti-hypertensive agent. Clin Exp Pharmacol Physiol 2018;45:755–66.

39. Hadi A, Ghaedi E, Moradi S, et al. Effects of Melatonin Supplementation On Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Horm Metab Res 2019;51:157–64.

40. Możdżan M, Możdżan M, Chałubiński M, et al. The effect of melatonin on circadian blood pressure in patients with type 2 diabetes and essential hypertension. Arch Med Sci 2014;10:669–75.

41. Grossman E, Laudon M, Zisapel N. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vasc Health Risk Manag 2011;7:577–84.

42. Rahbari-Oskoui FF, Abramson JL, Bruckman AM, et al. Nighttime administration of high-dose, sustained-release melatonin does not decrease nocturnal blood pressure in African-American patients: Results from a preliminary randomized, crossover trial. Complement Ther Med 2019;43:157–64.

43. Belcaro G, Cornelli U, Luzzi R, et al. Pycnogenol® supplementation improves health risk factors in subjects with metabolic syndrome. Phytother Res 2013;27:1572–8.

44. Hu S, Belcaro G, Cornelli U, et al. Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. Int Angiol 2015;34:43–52.

45. Pourmasoumi M, Hadi A, Mohammadi H, et al. Effect of pycnogenol supplementation on blood pressure: A systematic review and meta-analysis of clinical trials. Phytother Res 2020;34:67–76.

46. Zhang Z, Tong X, Wei YL, et al. Effect of Pycnogenol Supplementation on Blood Pressure: A Systematic Review and Meta-analysis. Iran J Public Health 2018;47:779–87.

47. Fogacci F, Tocci G, Sahebkar A, et al. Effect of Pycnogenol on Blood Pressure: Findings From a PRISMA Compliant Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled, Clinical Studies. Angiology 2020;71:217–25.

48. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause1999;6:7-13.

49. Rivas M, Garay RP, Escanero JF, et al. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 2002;132:1900-2.

50. Burke V, Hodgson JM, Beilin LJ, et al. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension2001;38:821-6.

51. He J, Gu D, Wu X, et al. Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann Intern Med 2005;143:1-9.

52. Welty FK, Lee KS, Lew NS, Zhou JR. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med 2007;167:1060-7.

53. Bkaily G, Jazzar A, Normand A, et al. Taurine and cardiac disease: state of the art and perspectives. Can J Physiol Pharmacol 2020;98:67–73.

54. Guizoni DM, Vettorazzi JF, Carneiro EM, et al. Modulation of endothelium-derived nitric oxide production and activity by taurine and taurine-conjugated bile acids. Nitric Oxide 2020;94:48–53.

55. Sun Q, Wang B, Li Y, et al. Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study. Hypertension 2016;67:541–9.

56. Waldron M, Patterson SD, Tallent J, et al. The Effects of Oral Taurine on Resting Blood Pressure in Humans: a Meta-Analysis.Curr Hypertens Rep 2018;20:81.

57. Morelli MB, Gambardella J, Castellanos V, et al. Vitamin C and Cardiovascular Disease: An Update. Antioxidants (Basel) 2020;9:1227.

58. Ran L, Zhao W, Tan X, et al. Association between Serum Vitamin C and the Blood Pressure: A Systematic Review and Meta-Analysis of Observational Studies. Cardiovasc Ther 2020;2020:4940673.

59. Myint PK, Luben RN, Wareham NJ, et al. Association between plasma vitamin C concentrations and blood pressure in the European prospective investigation into cancer-Norfolk population-based study. Hypertension 2011;58:372–9.

60. Guan Y, Dai P, Wang H. Effects of vitamin C supplementation on essential hypertension: A systematic review and meta-analysis. Medicine 2020;99:e19274.

61. Gambardella J, Khondkar W, Morelli MB, et al. Arginine and Endothelial Function. Biomedicines. 2020;8:277.

62. Khalaf D, Krüger M, Wehland M, et al. The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure. Nutrients 2019;11:1679.

63. Higashi Y, Oshima T, Watanabe M, et al. Renal response to L-arginine in salt-sensitive patients with essential hypertension. Hypertension 1996r;27:643–8.

64. Campese VM, Amar M, Anjali C, et al. Effect of L-arginine on systemic and renal haemodynamics in salt-sensitive patients with essential hypertension. J Hum Hypertens 1997;11:527–32.

65. Martelli A, Testai L, Colletti A, et al. Coenzyme Q10: Clinical Applications in Cardiovascular Diseases. Antioxidants (Basel) 2020;9:341.

66. Ho MJ, Li EC, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev 2016;3:CD007435.

67. Tabrizi R, Akbari M, Sharifi N, et al. The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials. High Blood Press Cardiovasc Prev 2018;25:41–50.

68. Walker AF, Marakis G, Morris AP, et al. Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension. Phytotherapy Res 2002;16:48–54.

69. Asgary S, Naderi GH, Sadeghi M, et al. Antihypertensive effect of Iranian Crataegus curvisepala Lind.: a randomized, double-blind study. Drugs Exp Clin Res 2004;30:221–5.

70. Walker AF, Marakis G, Simpson E, et al. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. Br J Gen Pract 2006;56:437–43.

71. Wang J, Xiong X, Feng B. Effect of crataegus usage in cardiovascular disease prevention: an evidence-based approach. Evid Based Complement Alternat Med 2013;2013:149363.

72. Asgary S, Keshvari M. Effects of Citrus sinensis juice on blood pressure. ARYA atheroscler 2013;9:98–101.

73. Morand C, Dubray C, Milenkovic D, et al. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 2011;93:73–80.

74. Valls RM, Pedret A, Calderón-Pérez L, et al. Effects of hesperidin in orange juice on blood and pulse pressures in mildly hypertensive individuals: a randomized controlled trial (Citrus study). Eur J Nutr 2021;60:1277–88.

75. Milenkovic D, Deval C, Dubray C, et al. Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study. PloS one 2011;6:e26669.

76. Homayouni F, Haidari F, Hedayati M, et al. Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial. Phytotherapy Res 2018;32:1073–9.

77. Alhabeeb H, Sohouli MH, Lari A, et al. Impact of orange juice consumption on cardiovascular disease risk factors: a systematic review and meta-analysis of randomized-controlled trials. Crit Rev Food Sci Nutr 2020:1–14.

78. Mohammadi M, Ramezani-Jolfaie N, Lorzadeh E, et al. Hesperidin, a major flavonoid in orange juice, might not affect lipid profile and blood pressure: A systematic review and meta-analysis of randomized controlled clinical trials. Phytother Res 2019 Mar;33:534–45.

79. Mas-Capdevila A, Teichenne J, Domenech-Coca C, et al. Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability. Nutrients. 2020;12:1488.

80. Romani A, Ieri F, Urciuoli S, et al. Health Effects of Phenolic Compounds Found in Extra-Virgin Olive Oil, By-Products, and Leaf of Olea europaea L. Nutrients 2019;11:1776.

81. Hermans MP, Lempereur P, Salembier JP, et al. Supplementation Effect of a Combination of Olive (Olea europea L.) Leaf and Fruit Extracts in the Clinical Management of Hypertension and Metabolic Syndrome. Antioxidants (Basel) 2020;9:872.

82. Lockyer S, Rowland I, Spencer JPE, et al. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial. Eur J Nutr 2017;56:1421–32.

83. Susalit E, Agus N, Effendi I, et al. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril. Phytomedicine 2011;18:251–8.

84. de la Guía-Galipienso F, Martínez-Ferran M, Vallecillo N, et al. Vitamin D and cardiovascular health. Clin Nutr 2021;40:2946–57.

85. Lin L, Zhang L, Li C, et al. Vitamin D and Vitamin D Receptor: New Insights in the Treatment of Hypertension. Curr Protein Pept 2019;20:984–95.

86. Zhang D, Cheng C, Wang Y, et al. Effect of Vitamin D on Blood Pressure and Hypertension in the General Population: An Update Meta-Analysis of Cohort Studies and Randomized Controlled Trials. Prev Chronic Dis 2020;17:E03.

87. Legarth C, Grimm D, Wehland M, et al. The Impact of Vitamin D in the Treatment of Essential Hypertension. Int J Mol Sci 2018;19:455.

88. He S, Hao X. The effect of vitamin D3 on blood pressure in people with vitamin D deficiency: A system review and meta-analysis. Medicine (Baltimore) 2019;98:e15284.

89. Zhu YB, Li ZQ, Ding N, et al. The association between vitamin D receptor gene polymorphism and susceptibility to hypertension: a meta-analysis. Eur Rev Med Pharmacol Sci 2019;23:9066–74.

90. Llopis-González A, Rubio-López N, Pineda-Alonso M, et al. Hypertension and the fat-soluble vitamins A, D and E. Int J Environ Res Public Health 2015;12:2793–809.

91. Kuwabara A, Nakade M, Tamai H, et al. The association between vitamin E intake and hypertension: results from the re-analysis of the National Health and Nutrition Survey. J Nutr Sci Vitaminol (Tokyo) 2014;60:239–45.

92. Ziegler M, Wallert M, Lorkowski S, et al. Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy? Antioxidants (Basel) 2020;9:935.

93. Emami MR, Safabakhsh M, Alizadeh S, et al. Effect of vitamin E supplementation on blood pressure: a systematic review and meta-analysis. J Hum Hypertens 2019;33:499–507.

94. Ramanathan N, Tan E, Loh LJ, et al. Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities. Nutr Metab (Lond) 2018;15:6.

95. Asgary S, Naderi GH, Sarrafzadegan N, et al. Antihypertensive and antihyperlipidemic effects of Achillea wilhelmsii. Drugs Exp Clin Res 2000;26:89–93.

96. Khan AU, Gilani AH. Blood pressure lowering, cardiovascular inhibitory and bronchodilatory actions of Achillea millefolium. Phytothe Res 2011;25:577–83.

97. Arias-Durán L, Estrada-Soto S, Hernández-Morales M, et al. Antihypertensive and vasorelaxant effect of leucodin and achillin isolated from Achillea millefolium through calcium channel blockade and NO production: In vivo, functional ex vivo and in silico studies. J Ethnopharmacol 2021;273:113948.

98. de Souza P, Gasparotto A, Crestani S, et al. Hypotensive mechanism of the extracts and artemetin isolated from Achillea millefolium L. (Asteraceae) in rats. Phytomedicine 2011;18:819–25.

99. Niazmand S, Harandizadeh F, Mahmoudabady M, et al. Mechanism of vasorelaxation induced by Achillea wilhelmsii in rat isolated thoracic aorta. Adv Biomed Res 2014;3:91.

100. Sun X, Li H, He X, et al. The association between calcium supplement and preeclampsia and gestational hypertension: a systematic review and meta-analysis of randomized trials. Hypertens Pregnancy 2019;38:129–39.

101. Cormick G, Belizán JM. Calcium Intake and Health. Nutrients 2019;11:1606.

102. Cormick G, Ciapponi A, Cafferata ML, et al. Calcium supplementation for prevention of primary hypertension. Cochrane Database Syst Rev 2015;6:Cd010037.

103. van Mierlo LA, Arends LR, Streppel MT, et al. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 2006;20:571–80.

104. Hulbert M, Turner ME, Hopman WM, et al. Changes in vascular calcification and bone mineral density in calcium supplement users from the Canadian Multi-center Osteoporosis Study (CaMOS). Atherosclerosis 2020;296:83–90.

105. Khan SU, Khan MU, Riaz H, et al. Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map. Ann Intern Med 2019;171:190–8.

106. Myung SK, Kim HB, Lee YJ, et al. Calcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical Trials. Nutrients 2021;13:368.

107. Morvaridzadeh M, Sepidarkish M, Fazelian S, et al. Effect of Calcium and Vitamin D Co-supplementation on Blood Pressure: A Systematic Review and Meta-Analysis. Clin Ther 2020;42:e45–e63.

108. Dubey MP, Srimal RC, Nityanand S, Dhawan BN. Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii. J Ethnopharmacol 1981;3:1–13.

109. Lindner E, Dohadwalla AN, Bhattacharya BK. Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohli: Forskolin. Arzneimittelforschung. 1978;28:284–9.

110. Jagtap M, Chandola HM, Ravishankar B. Clinical efficacy of Coleus forskohlii (Willd.) Briq. (Makandi) in hypertension of geriatric population. Ayu. 2011;32:59–65.

111. Baumann G, Felix S, Sattelberger U, Klein G. Cardiovascular effects of forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy—a comparative study with dobutamine and sodium nitroprusside. J Cardiovasc Pharmacol 1990;16:93–100.

112. Zhang B, Liu J, Liu C, et al. Bifunctional peptides with antioxidant and angiotensin-converting enzyme inhibitory activity in vitro from egg white hydrolysates. J Food Biochem 2020 09;44:e13347.

113. Lee DE, Jung TH, Jo YN, et al. Enzymatic Hydrolysis of Egg White Protein Exerts a Hypotensive Effect in Spontaneously Hypertensive Rats. Food Sci Anim Resour 2019;39:980–7.

114. Plat J,Severins N, Morrison S, et al. Effects of NWT-03, an egg-protein hydrolysate, on blood pressure in normotensive, high-normotensive and mild-hypertensive men and women: a dose-finding study. Br J Nutr 2017;117:942–50.

115. Lucey AJ, Heneghan C, Manning E, et al. Effect of an egg ovalbumin-derived protein hydrolysate on blood pressure and cardiovascular risk in adults with a mildly elevated blood pressure: a randomized placebo-controlled crossover trial. Eur J Nutr 2019;58:2823–33.

116. Samsamikor M, Mackay D, Mollard RC, et al. A double-blind, randomized, crossover trial protocol of whole hemp seed protein and hemp seed protein hydrolysate consumption for hypertension. Trials 2020;21:354.

117. Malomo SA, Onuh JO, Girgih AT, et al. Structural and Antihypertensive Properties of Enzymatic Hemp Seed Protein Hydrolysates. Nutrients 2015;7:7616–32.

118. Girgih AT, Alashi AM, He R, et al. A novel hemp seed meal protein hydrolysate reduces oxidative stress factors in spontaneously hypertensive rats. Nutrients 2014;6:5652–66.

119. Girgih A, Alashi A, He R, et al. Preventive and treatment effects of a hemp seed (Cannabis sativa L.) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats. Eur J Nutr 2014;53:1237–46.

120. Lobay D. Rauwolfia in the Treatment of Hypertension. Integr Med (Encinitas) 2015;14:40–6.

121. Shamon SD,Perez MI. Blood pressure-lowering efficacy of reserpine for primary hypertension. Cochrane Database Syst Rev 2016;12:CD007655.

122. Ryan JJ, Hanes DA, Corroon J, et al. Prospective Safety Evaluation of a Cardiovascular Health Dietary Supplement in Adults with Prehypertension and Stage I Hypertension. J Altern Complement Med 2019;25:249–56.

123. Poggiogalle E, Fontana M, Giusti AM, et al. Amino Acids and Hypertension in Adults. Nutrients 2019;11:1459.

124. Feltkamp H, Meurer KA, Godehardt E. Tryptophan-induced lowering of blood pressure and changes of serotonin uptake by platelets in patients with essential hypertension. Klin Wochenschr 1984;62:1115–9.

125. Cade JR, Fregly MJ, Privette M. Effect of tryptophan and 5-hydroxytryptophan on the blood pressure of patients with mild to moderate hypertension. Amino Acids 1992;2:133–42.

126. Nazaruk J, Orlikowski P. Phytochemical profile and therapeutic potential of Viscum album L. Nat Prod Res 2016;30:373–85.

127. Khan T, Ali S, Qayyum R, et al. Intestinal and vascular smooth muscle relaxant effect of Viscum album explains its medicinal use in hyperactive gut disorders and hypertension. BMC Complement Altern Med 2016;16:251.

128. Poruthukaren KJ, Palatty PL, Baliga MS, et al. Clinical evaluation of Viscum album mother tincture as an antihypertensive: a pilot study. J Evid Based Complementary Altern Med 2014;19:31–5.

129. Bowman IA. The everlasting mistletoe and the cardiovascular system. Texas Heart Inst J 1990;17:310–4.

130. Teunissen-Beekman KF, Dopheide J,Geleijnse JM, et al. Dietary proteins improve endothelial function under fasting conditions but not in the postprandial state, with no effects on markers of low-grade inflammation. Br J Nutr 2015;114:1819–28.

131. Teunissen-Beekman KF, Dopheide J,Geleijnse JM, et al. Differential effects of proteins and carbohydrates on postprandial blood pressure-related responses. Br J Nutr 2014;112:600–8.

132. Dugardin C, Cudennec B, Tourret M, et al. Explorative Screening of Bioactivities Generated by Plant-Based Proteins after In Vitro Static Gastrointestinal Digestion. Nutrients 2020;12:3746.

133. Teunissen-Beekman K, Dopheide J, Geleijnse J, et al. Protein supplementation lowers blood pressure in overweight adults: effect of dietary proteins on blood pressure (PROPRES), a randomized trial. Am J Clin Nutr 2012;95:966–71.

134. Li H, PrairieN, Udenigwe C, et al. Blood pressure lowering effect of a pea protein hydrolysate in hypertensive rats and humans. J Agric Food Chem 2011;59:9854–60.

135. Tran HB, Yamamoto A, Matsumoto S, et al. Hypotensive effects and angiotensin-converting enzyme inhibitory peptides of reishi (Ganoderma lingzhi) auto-digested extract. Molecules 2014;19:13473–85.

136. Wu Q, Li Y, Peng K, et al. Isolation and Characterization of Three Antihypertension Peptides from the Mycelia of Ganoderma Lucidum (Agaricomycetes). J Agric Food Chem 2019;67:8149–59.

137. Chu TT, Benzie IF, Lam CW, et al. Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. Br J Nutr 2012;107:1017–27.

138. Klupp NL, Kiat H, Bensoussan A, et al. A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Sci Rep 2016;6:29540.

139. Jin H, Zhang G, Cao X, et al. Treatment of hypertension by ling zhi combined with hypotensor and its effects on arterial, arteriolar and capillary pressure and microcirculation. In: Nimmi H, Xiu RJ, Sawada T, Zheng C (eds). Microcirculatory Approach to Asian Traditional Medicine. New York: Elsevier Science, 1996, 131–8.

140. Olas B. Sea buckthorn as a source of important bioactive compounds in cardiovascular diseases. Food Chem Toxicol 201697:199–204.

141. Skalski B, Kontek B, Olas B, et al. Phenolic fraction and nonpolar fraction from sea buckthorn leaves and twigs: chemical profile and biological activity. Future Med Chem 2018;10:2381–94.

142. Zhou F, Zhang J, Zhao A, et al. Effects of sea buckthorn puree on risk factors of cardiovascular disease in hypercholesterolemia population: a double-blind, randomized, placebo-controlled trial. Anim Biotechnol 2020:1–9.

143. Vashishtha V, Barhwal K, Kumar A, et al. Effect of seabuckthorn seed oil in reducing cardiovascular risk factors: A longitudinal controlled trial on hypertensive subjects. Clin Nutr 2017;36:1231–8.

144. Markovitz JH, Matthews KA, Kannel WB, et al. Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension?JAMA 1993;270:2439-43.

145. Schnall PL, Schwartz JE, Landesbergis PA, et al. Relation between job strain, alcohol, and ambulatory blood pressure. Hypertension 1992;19:488-94.

146. Matthews KA, Cottington EM, Talbott E, et al. Stressful work conditions and diastolic blood pressure among blue collar factory workers. Am J Epidemiol 1987;126:280-91.

147. Pickering TG. Does psychological stress contribute to the development of hypertension and coronary heart disease? Eur J Clin Pharmacol 1990;39(Suppl 1):S1-S7.

148. Perini C, Müller FB, Bühler FR. Suppressed aggression accelerates early development of essential hypertension. J Hypertens 1991;9:499-503.

149. Eisenberg DM, Delbanco TL, Berkey CS, et al. Cognitive behavioral techniques for hypertension: are they effective? Ann Intern Med 1993;118:964-72.

150. Irvine MJ, Logan AG. Relaxation behavior therapy as sole treatment for mild hypertension. Psychosomatic Med 1991;53:587-97.

151. Johnston DW, Gold A, Kentish J, et al. Effect of stress management on blood pressure in mild primary hypertension. BMJ 1993;306:963-6.

152. Patel CH. Yoga and bio-feedback in the management of hypertension. Lancet 1973;2:1973-5.

153. Schneider RH, Staggers F, Alexander C, et al. A randomized controlled trial of stress reduction for hypertension in older African Americans. Hypertension 1995;26:820-9.

154. Patel C, Marmot MG, Terry DJ, et al. Trial of relaxation in reducing coronary risk: four year follow up. BMJ 1985;290:1103-6.

155. Lee HS, Kim JY. Effects of acupuncture on blood pressure and plasma renin activity in two-kidney one clip goldblatt hypertensive rats. Am J Chin Med 1994;22:215-9.

156. Chiu YJ, Chi A, Reid IA. Cardiovascular and endocrine effects of acupuncture in hypertensive patients. Clin Exper Hypertens 1997;19:1047-63.

157. Peng L, Feng-yen S, An-zhong Z. The effect of acupuncture on blood pressure: the interrelation of sympathetic activity and endogenous opioid peptides. Acupunct Electrother Res 1983;8:45-56.

158. Zhou Y, Wang Y, Fang Z, et al. Influence of acupuncture on blood pressure, contents of NE, DA and 5-HT of SHR and the interrelation between blood pressure and whole blood viscosity. Chen Tzu Yen Chiu 1995;20:55-61 [in Chinese].

159. Radzievsky SA, Lebedeva OD, Fisenko LA, Majskaja SA. Function of myocardial contraction and relaxation in essential hypertension in dynamics of acupuncture therapy. Am J Chin Med 1989;17:111-7.

160. Williams T, Mueller K, Cornwall MW. Effect of acupuncture-point stimulation on diastolic blood pressure in hypertensive subjects: a preliminary study. Phys Ther 1991;71:523-9.

161. Weihai Y, Hongxu L. Clinical observation on the immediate hypotensive effect of zanzhu point. J Tradit Chin Med 1996;16:273-4.

162. Utsunomiya N, Shigematsu Y, Ikeda K, et al. Fall in high blood pressure after applying acupuncture to SHR. Jpn Heart J 1978;19:594.

163. Yiping Z, Qiong C, Zhengming H, Yinong C. Experimental research on treatment of hypertension with acupuncture. J Tradit Chin Med 1993;13:277-80.

164. Tam K-C, Yiu H-H. The effect of acupuncture on essential hypertension. Am J Chin Med 1975;3:369-75.

165. Kraft K, Coulon S. Effect of a standardized acupuncture treatment on complains, blood pressure and serum lipids of hypertensive, postmenopausal women. A randomized, controlled clinical study. Forsch Komplementarmed 1999;6:74-9 [in German].

166. Rongxing Z, Yanhua Z, Lu Y. Hypotensive effect of ototherapy in relation to symptomatic and dispositional types of patients. J Tradit Chin Med 1992;12:124-8.

167. Kangmei C, Shulian Z, Ying Z. Clinical application of traditional auriculoacupoint therapy (continued). J Tradit Chin Med 1993;13:152-4.

168. Rongxing Z, Yanhua Z, Jialiang W, et al. Anti-hypertensive effect of auriculo-acupoint pressing therapy—clinical analysis of 274 cases. J Tradit Chin Med 1991;11:189-92.

169. Peng Y, Fenglan L, Xin W. Treatment of essential hypertension with auriculopressure. J Tradit Chin Med 1991;1117-21.

170. Tran T, Kirby J. Effects of upper cervical adjustments upon the normal physiology of the heart. ACA J Chiro 1977;XI:S58-62.

171. McGuiness J, Vicenzino B, Wright A. The influence of a cervical mobilization technique on respiratory and cardiovascular function. Man Ther 1997;2:216-20.

172. Vicenzino B, Cartwright T, Collins D. Cardiovascular and respiratory changes produced by lateral glide mobilization of the cervical spine Manual Therapy 1998;3(2):67-71.

173. Dulgar G, Hill D, Sirucek A, et al. Evidence for possible anti-hypertensive effect of basic technique apex contact adjusting. J Chiro 1980;14:S97-S102.

174. Nansel D, Jansen R, Cremata E, et al. Effects of cervical adjustments on lateral-flexion passive end-range asymmetry and on blood pressure, heart rate and plasma catecholamine levels. J Manipulative Physiol Ther 1991;14:450-6.

175. Fichera AP, Celander DR. Effect of osteopathic manipulative therapy on autonomic tone as evidenced by blood pressure change and activity of the fibrinolytic system. J Am Osteopath Assoc 1969;68:1036-8.

176. McKnight M, DeBoer KD. Preliminary study of blood pressure changes in normotensive patients under chiropractic care. J Manipulative Physiol Ther 1988;11:261-6.

177. Yates RG, Lamping DL, Nancy LA, Wright C. Effects of chiropractic treatment on blood pressure and anxiety: a randomized, controlled trial. J Manipulative Physiol Ther 1988;11:484-8.

178. Morgan JP, Dickey JL, Hunt HH, Hudgins PM. A controlled trial of spinal manipulation in the management of hypertension. J Am Osteopath Assoc 1985;85(5):308-12.

179. Mannino J. The application of neurologic reflexes to the treatment of hypertension. J Am Osteopath Assoc 1979;79:225-31.

180. Wagnon RJ, Sandefur RM, Ratliff CR. Serum aldosterone changes after specific chiropractic manipulation. Am J Chiropr Med 1988;1(2):66-70.

181. Goodman R. Hypertension and the atlas subluxation complex. Chiropractic: J Chiropractic Res Clin Invest 1992;8(2)30-2.

182. Rossner S, Andersson IL, Ryttig K. Effects of a dietary fibre supplement to a weight reduction programme on blood pressure. A randomized, double-blind, placebo-controlled study. Acta Med Scand 1988;223:353-7.

183. Eliasson K, Ryttig KR, Hylander B, Rossner S. A dietary fibre supplement in the treatment of mild hypertension. A randomized, double-blind, placebo-controlled trial. J Hypertens 1992;10:195-9.

184. Schlamowitz P, Halberg T, Warnoe O, et al. Treatment of mild to moderate hypertension with dietary fibre. Lancet 1987;2:622-3.

185. Fehily AM, Burr ML, Butland BK, Eastham RD. A randomised controlled trial to investigate the effect of a high fibre diet on blood pressure and plasma fibrinogen. J Epidemiol Community Health 1986;40:334-7.

186. Swain JF, Rouse IL, Curley CB, Sacks FM. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med 1990;322:147-52.

187. Rachima-Maoz C, Peleg E, Rosenthal T. The effect of caffeine on ambulatory blood pressure in hypertensive patients. Am J Hypertens 1998;11:1426-32.

188. Hodgoson JM, Buddey IB, Burke V, et al. Effects on blood pressure of drinking green and black tea. J Hypertens 1999;17:457-63.

189. Jee SH, He J, Whelton PK, et al. The effect of chronic coffee drinking on blood pressure. A meta-analysis of controlled clinical trials. Hypertension 1999;33:647-52.

190. Wakabayashi K, Kono S, Shinchi K, et al. Habitual coffee consumption and blood pressure: a study of self-defense officials in Japan. Eur J Epidemiol 1998;14:669-73.

191. Soriguer F, Rojo-Martinez G, Dobarganes MC, et al. Hypertension is related to the degradation of dietary frying oils. Am J Clin Nutr 2003;78:1092-7.

192. Page LB, Damon A, Moellering RC Jr. Antecedents of cardiovascular disease in six Solomon Islands Societies. Circulation 1974;44:1132-46.

193. Stamler J, Rose G, Elliott P, et al. Findings of the international cooperative INTERSALT study. Hypertension 1991;17(1 Suppl):I9-15.

194. MacGregor GA, Markandu ND, Sagnella GA, et al. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet 1989;2:1244-7.

195. Cutler JA, Follmann D, Allender PS. Randomized trials of sodium reduction: an overview. Am J Clin Nutr 1997;65(Suppl):643S-51S.

196. Egan BM, Stepniakowski KT. Adverse effects of short-term, very-low-salt diets in subjects with risk-factor clustering. Am J Clin Nutr 1997;65(Suppl):671S-7S.

197. Engelhard YN, Gazer B, Paran E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 2006;151:100.

198. Margetts BM, Beilin LJ, Vandongen R, Armstrong BK. Vegetarian diet in mild hypertension: a randomised controlled trial. BMJ 1986;293:1468-71.

199. Cappuccio FP, MacGregor GA. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens 1991;9:465-73.

200. Appel LJ, Moore TJ, Boarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-24.

201. Svetkey LP, Simons-Morton D, Vollmer WM, et al. Effects of dietary patterns on blood pressure: a subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 1999;159:285-93.

202. Sachs FM, Svetkey LP, Vollmer WM, et al. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001;344:3-10.

203. Zein M, Areas JL, Breuss GH. Effects of excess sucrose ingestion on the lifespan of SHR. J Am Coll Nutr 1989;8:435 [abstract #42].

204. Rebello T, Hodges RE, Smith JL. Short-term effects of various sugars on antinatriuresis and blood pressure changes in normotensive young men. Am J Clin Nutr 1983;38(1):84-94.

205. Preuss HG, Fournier RD. Effects of sucrose ingestion on blood pressure. Life Sci 1982;30:879-86.

206. Grant EC. Food allergies and migraine. Lancet 1979;i:966-9.

207. Narkiewicz K, Maraglino G, Biasion T, et al. Interactive effect of cigarettes and coffee on daytime systolic blood pressure in patients with mild essential hypertension. J Hypertens 1995;13:965-70.

208. Keil U, Liese A, Filipiak B, et al. Alcohol, blood pressure and hypertension. Novartis Round Symp 1998;216:125-44 [review].

209. Kukkonen K, Rauramaa R, Voutilainene E, Lansimies E. Physical training of middle-aged men with borderline hypertension. Ann Clin Res 1982;14(Suppl 34):139-45.

210. Young DR, Appel LG, Jee SH, Miller ER III. The effect of aerobic exercise and T'ai Chi on blood pressure in older people: results of a randomized trial. J Am Geriatr Soc 1999;47:277-84.

211. Kelley GA, Kelley KS. Progressive resistance exercise and resting blood pressure. A meta-analysis of randomized controlled trials. Hypertension 2000;35:838-43.

212. Alderman MH. Nonpharmacologic approaches to the treatment of hypertension. Lancet 1994;334:307-11 [review].

213. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, Phase II. Ann Intern Med 2001;134:1-11.

214. He J, Whelton PK, Appel LJ, et al. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000;35:544-9.

215. G Bakris, M Dickholtz, P M Meyer, et al. Journal of Human Hypertension 21, 347-52; doi:10.1038/sj.jhh.1002133

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. Self-treatment is not recommended for life-threatening conditions that require medical treatment under a doctor's care. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.

drug Image
Check Pricing on Drugs Commonly Used to Treat hypertension:

Select drug name to view medication information and pricing.

Log In

You need to log into the site to use this feature

Create A Free Account To Use Medicine Chest

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use Medicine Chest

Create A Free Account To Use this feature

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use this feature

You will be redirected to your program in 5 seconds.

Hi there.

Our Terms and Conditions and Privacy Policy have recently been updated.

Learn More


I Accept

By declining you will be logged out of your account

;